Entasis Therapeutics Statistics Share Statistics Entasis Therapeutics has 0
shares outstanding. The number of shares has increased by 28.25%
in one year.
Shares Outstanding n/a Shares Change (YoY) 28.25% Shares Change (QoQ) 0.45% Owned by Institutions (%) n/a Shares Floating 15.99M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 143.28K, so 0% of the outstanding
shares have been sold short.
Short Interest 143.28K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.46
Valuation Ratios The PE ratio is -2.2 and the forward
PE ratio is null.
Entasis Therapeutics's PEG ratio is
0.04.
PE Ratio -2.2 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 3.32 P/FCF Ratio -2.41 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Entasis Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.1,
with a Debt / Equity ratio of 0.
Current Ratio 4.1 Quick Ratio 4.1 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-924.33K Employee Count 51 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.33, so Entasis Therapeutics's
price volatility has been higher than the market average.
Beta 1.33 52-Week Price Change n/a 50-Day Moving Average 2.06 200-Day Moving Average n/a Relative Strength Index (RSI) 62.73 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -47.14M Net Income -47.14M EBITDA -47.04M EBIT -47.14M Earnings Per Share (EPS) -1
Full Income Statement Balance Sheet The company has 32.31M in cash and 0 in
debt, giving a net cash position of 32.31M.
Cash & Cash Equivalents 32.31M Total Debt n/a Net Cash n/a Retained Earnings -231.6M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -42.97M
and capital expenditures -70K, giving a free cash flow of -43.04M.
Operating Cash Flow -42.97M Capital Expenditures -70K Free Cash Flow -43.04M FCF Per Share -0.91
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
